| 영문 | iron | 한글 | 철 |
|---|---|---|---|
| 설명 | 금속원소. 기호 Fe. 원자번호 26. 혈색소와 cytochrome, 기타 호흡기 계통의 효소를 구성하는 중요한 원소이다. |
||
| 영문 | iron deficiency anemia | 한글 | 철결핍빈혈 |
|---|---|---|---|
| 설명 | 적혈구의 기능은 산소를 운반하는데 있다. 적혈구 속에 산소와 결합을 하여 산소를 운반하는 혈색소라는 물질이 있다. 철은 이 혈색소의 중요한 부분을 이루는 것으로 철이 없으면 혈색소가 만들어질 수가 없다. 혈색소가 없으면 역시 적혈구도 만들어지지 않으므로 체내에 철이 부족하면 빈혈이 생긴다. 이 철결핍성 빈혈은 빈혈의 원인 중에서 가장 흔한 것이다(약 25%를 차지한다). 철저장량의 저하-결핍, 혈청철농도의 저하, 트란스페린량 상승, 트란스페린포화도의 저하, 혈색소농도 또는 헤마토크리트의 저하, 저색소성대적혈구를 특징으로 하는 빈혈로서, 생체 내에서 철이 장기에 걸쳐 결핍되며 그 때문에 혈색소 생산 감소에 의해 일어난다. 창자에서의 철흡수량 부족, 철의 수요 증대(유아기, 사춘기, 임신), 철소실과잉(출혈)에 의해 일어나며, 특히 사춘기에서 폐경기까지의 여성에게 많다. 증상으로서는 얼굴창백, 피로감, 피부창백, 손톱 변화(스푼 모양) 등을 나타낸다. 구강 영역에서는 혀의 접촉통, 발적, 건조감, 삼킴곤란을 수반하면 플러머-빈슨(Plummer-Vinson)증후군이라고 한다. 혈액 소견은 혈청철은 저하하며, 철결합능력의 상승, 저색소성 작은적혈구성을 나타낸다. |
||
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
|---|---|
| DB | data base; date of birth; deep breath; dense body; dextran blue; diabetes, diabetic; diagonal band; ... |
| DC | daily census; data communication; data conversion; decrease; deep compartment; Dental Corps; deoxych... |
| DCC | day care center; detected in colon cancer; dextran-coated charcoal; diameter of cylindrical collimat... |
| DEAE-D | diethylaminoethyl dextran |
| FITC-dextran | Fluorescein-isothiocyanate dextran |
|---|---|
| DEAE-Dextran | diethyl-amino-ethyl-dextran |
| AED | Aminoethyl dextran |
| BDA | Biotinylated dextran amine |
| D | Dextran |
| iron-dextran complex | <chemical> Iron dextran. A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a haematinic. (goodman and gilman's the pharmacological basis of therapeutics, 8th ed, p1292) Pharmacological action: haematinics. Chemical name: Iron dextran (12 Dec 1998) |
|---|---|
| acid dextran | The product of acid and heat treatment of dextran. (05 Mar 2000) |
| animal dextran | <biochemistry> Branched polymer of D glucose (mostly _(1-4) linked, but some _(1-6) at branch points). Size range very variable, up to 10exp5 glucose units. Major short term storage polymer of animal cells and is particularly abundant in the liver and to a lesser extent in muscle. In the electron microscope glycogen has a characteristic asterisk or star appearance. (18 Nov 1997) |
| blue dextran | High molecular weight dextran containing a blue chlorotriazine dye, Cibacron Blue; used to measure the void volumes in gel filtration columns. (05 Mar 2000) |
| deae-dextran | <chemical> Diethylaminoethyldextran. Used as a support for ion-exchange chromatography. Chemical name: Dextran, 2-(diethylamino)ethyl ether (12 Dec 1998) |
| dextran | High molecular weight polysaccharides synthesised by some micro organisms. Consist of D glucose linked by _ 1,6 bonds (and a few _ 1,3 and _ 1,4 bonds). Dextran 75 (average molecular weight 75 kD) has a colloid osmotic pressure similar to blood plasma, so dextran 75 solutions are used clinically as plasma expanders. They will also cause charge shielding and at the right concentrations induce flocculation of red cells, a trick that is used in preparing leucocyte rich plasma for white cell purification in the laboratory. Cross linked dextran is the basis for Sephadex. Commercially derived from strains of Leuconostoc mesenteroides. (18 Nov 1997) |
| dextran 110 | Dextran (average MW 110,000) available as 5% solution in water or saline solution; used as a plasma volume expander. (05 Mar 2000) |
| dextran 40 | Dextran (average MW 40,000) used as a plasma volume expander and blood flow adjuvant. (05 Mar 2000) |
| dextran 70 | Dextran (average MW 70,000) used as a plasma volume expander. (05 Mar 2000) |
| dextran 75 | Dextran (average MW 75,000) used as a plasma volume expander. (05 Mar 2000) |
| dextran sulfate | <chemical> Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4+ T-lymphocytes. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications. Pharmacological action: anticoagulant, antiviral agents, indicators and reagents, plasma substitutes. Chemical name: Dextran, hydrogen sulfate (12 Dec 1998) |
| dextrin-dextran transglucosidase | A glucosyltransferase transferring 1,4-alpha-d-glucosyl residues, thus catalyzing the synthesis of dextrans (with 1,6 links between monosaccharide units) from dextrins (with 1,4 links) by glucose transfer. Synonym: dextrin-dextran transglucosidase, dextrin 6-glucosyltransferase. (05 Mar 2000) |
| albuminised iron | Iron albuminate, a compound of iron oxide and albumin; rendered soluble by the presence of sodium citrate; occurs as reddish brown, lustrous granules, odourless or nearly so; used in anaemia. (05 Mar 2000) |
| anaemia, iron deficiency | Deficiency of iron results in anaemia because iron is necessary to make haemoglobin, the key molecule in red blood cells responsible for the transport of oxygen. In iron deficiency anaemia, the red cells are unusally small (microcytic) and pale (hypochromic). Characteristic features of iron deficiency anaemia in children include failure to thrive (grow) and increased infections. The treatment of iron deficiency anaemia, whether it be in children or adults, is with iron and iron-containing foods. Food sources of iron include meat, poultry, eggs, vegetables and cereals (especially those fortified with iron). According to the National Academy of Sciences, the Recommended Dietary Allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men. Anaemia characterised by low or absent iron stores, low serum iron concentration, elevated free erythrocyte porphorin, low transferrin saturation, elevated transferrin, low serum ferritin, low haemoglobin concentration or haematocrit, and hypochromic microcytic red blood cells. Symptoms may include pallor, angular stomatitis and other oral lesions, gastrointestinal complaints, retinal haemorrhages and exudates, and thinning and brittleness of the nails. Among the causes of iron-deficiency anaemia are inadequate iron intake, impaired iron absorption, increased blood loss and increased requirements such as infancy, pregnancy, and lactation. (12 Dec 1998) |
| brain iron | <radiology> Normal, Infant: NONE, Adult: globus pallidum, substantia nigra, red nucleus, dentate nucleus, Aging: (adult) and putamen, Degenerative disease, Parkinson disease: putamen, SN compacta, Huntington disease: caudate, putamen, Alzheimer disease: cerebral cortex, Hallervorden-Spatz disease, MS: thalamus, putamen, Others, AVM: malformation and rim, Bleed: rim macrophages, Haemorrhagic CVA: gyral / basal ganglia MRI: low T1 and T2 signal (12 Dec 1998) |
| iron dextran injection |
A preparation of iron suitable for parenteral use.
출처:
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|